226 related articles for article (PubMed ID: 20869952)
1. Effect in vitro of apolipoprotein A-V on the structure and functions of recombinant high density lipoprotein.
Zhang X; Wang J; Chen B
Biochem Biophys Res Commun; 2010 Oct; 401(3):473-9. PubMed ID: 20869952
[TBL] [Abstract][Full Text] [Related]
2. Function of different proportions of apolipoprotein A-I cysteine mutants and apolipoprotein A-V on recombinant high-density lipoproteins
Yan Y; Lu S; Jia S; Dong Q; Wang L; Wang Y
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31023964
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of recombinant high density lipoprotein with apolipoprotein A-I and apolipoprotein A-V.
Zhang X; Chen B
Biol Chem; 2011 May; 392(5):423-9. PubMed ID: 21476871
[TBL] [Abstract][Full Text] [Related]
4. Structure-function relationships in reconstituted HDL: Focus on antioxidative activity and cholesterol efflux capacity.
Cukier AMO; Therond P; Didichenko SA; Guillas I; Chapman MJ; Wright SD; Kontush A
Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Sep; 1862(9):890-900. PubMed ID: 28529180
[TBL] [Abstract][Full Text] [Related]
5. Structural and Functional Changes of Reconstituted High-Density Lipoprotein (HDL) by Incorporation of α-synuclein: A Potent Antioxidant and Anti-Glycation Activity of α-synuclein and apoA-I in HDL at High Molar Ratio of α-synuclein.
Cho KH
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946565
[TBL] [Abstract][Full Text] [Related]
6. Fructated apolipoprotein A-I showed severe structural modification and loss of beneficial functions in lipid-free and lipid-bound state with acceleration of atherosclerosis and senescence.
Park KH; Jang W; Kim KY; Kim JR; Cho KH
Biochem Biophys Res Commun; 2010 Feb; 392(3):295-300. PubMed ID: 20059975
[TBL] [Abstract][Full Text] [Related]
7. Different Functional and Structural Characteristics between ApoA-I and ApoA-4 in Lipid-Free and Reconstituted HDL State: ApoA-4 Showed Less Anti-Atherogenic Activity.
Yoo JA; Lee EY; Park JY; Lee ST; Ham S; Cho KH
Mol Cells; 2015 Jun; 38(6):573-9. PubMed ID: 25997739
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional properties of reconstituted high density lipoprotein discs prepared with six apolipoprotein A-I variants.
Jonas A; von Eckardstein A; Kézdy KE; Steinmetz A; Assmann G
J Lipid Res; 1991 Jan; 32(1):97-106. PubMed ID: 1901346
[TBL] [Abstract][Full Text] [Related]
9. Multifunctional Dextran Sulfate-Coated Reconstituted High Density Lipoproteins Target Macrophages and Promote Beneficial Antiatherosclerotic Mechanisms.
Zhao Y; Jiang C; He J; Guo Q; Lu J; Yang Y; Zhang W; Liu J
Bioconjug Chem; 2017 Feb; 28(2):438-448. PubMed ID: 28004910
[TBL] [Abstract][Full Text] [Related]
10. Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer.
Calabresi L; Canavesi M; Bernini F; Franceschini G
Biochemistry; 1999 Dec; 38(49):16307-14. PubMed ID: 10587455
[TBL] [Abstract][Full Text] [Related]
11. Structure and stability of apolipoprotein a-I in solution and in discoidal high-density lipoprotein probed by double charge ablation and deletion mutation.
Gorshkova IN; Liu T; Kan HY; Chroni A; Zannis VI; Atkinson D
Biochemistry; 2006 Jan; 45(4):1242-54. PubMed ID: 16430220
[TBL] [Abstract][Full Text] [Related]
12. ω-6 (18:2) and ω-3 (18:3) fatty acids in reconstituted high-density lipoproteins show different functionality of anti-atherosclerotic properties and embryo toxicity.
Park KH; Kim JY; Choi I; Kim JR; Cho KH
J Nutr Biochem; 2015 Dec; 26(12):1613-21. PubMed ID: 26363928
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of collar-induced carotid atherosclerosis by recombinant apoA-I cysteine mutants in apoE-deficient mice.
Zhang X; Zhu X; Chen B
J Lipid Res; 2010 Dec; 51(12):3434-42. PubMed ID: 20817832
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein A-II inhibits high density lipoprotein remodeling and lipid-poor apolipoprotein A-I formation.
Rye KA; Wee K; Curtiss LK; Bonnet DJ; Barter PJ
J Biol Chem; 2003 Jun; 278(25):22530-6. PubMed ID: 12690114
[TBL] [Abstract][Full Text] [Related]
15. Intravenous injection of apolipoprotein A-V reconstituted high-density lipoprotein decreases hypertriglyceridemia in apoav-/- mice and requires glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1.
Shu X; Nelbach L; Weinstein MM; Burgess BL; Beckstead JA; Young SG; Ryan RO; Forte TM
Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2504-9. PubMed ID: 20966404
[TBL] [Abstract][Full Text] [Related]
16. Oxidized phospholipid content destabilizes the structure of reconstituted high density lipoprotein particles and changes their function.
Kar S; Patel MA; Tripathy RK; Bajaj P; Suvarnakar UV; Pande AH
Biochim Biophys Acta; 2012 Sep; 1821(9):1200-10. PubMed ID: 22634518
[TBL] [Abstract][Full Text] [Related]
17. A reconstituted high density lipoprotein containing the V156E mutant of apolipoprotein A-I exhibits anti-atherosclerotic activity in Apo-E deficient mice.
Cho KH
J Atheroscler Thromb; 2009 Jun; 16(3):217-29. PubMed ID: 19638715
[TBL] [Abstract][Full Text] [Related]
18. Cuban Sugar Cane Wax Alcohol Exhibited Enhanced Antioxidant, Anti-Glycation and Anti-Inflammatory Activity in Reconstituted High-Density Lipoprotein (rHDL) with Improved Structural and Functional Correlations: Comparison of Various Policosanols.
Cho KH; Baek SH; Nam HS; Kim JE; Kang DJ; Na H; Zee S
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834595
[TBL] [Abstract][Full Text] [Related]
19. Bovine apolipoprotein (apo)A-I displays more enhanced antioxidant and anti-atherosclerotic activity in lipid-free and lipid-bound states than human and porcine apoA-I.
Kim SM; Park GY; Choi I; Cho KH
Int J Mol Med; 2013 Oct; 32(4):843-50. PubMed ID: 23969702
[TBL] [Abstract][Full Text] [Related]
20. A reconstituted HDL containing V156K or R173C apoA-I exhibited anti-inflammatory activity in apo-E deficient mice and showed resistance to myeloperoxidase-mediated oxidation.
Cho KH; Kim JR
Exp Mol Med; 2009 Jun; 41(6):417-28. PubMed ID: 19322022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
